Cargando…
NRF2-pathway mutations predict radioresistance in non-small cell lung cancer
Autores principales: | Kinslow, Connor J., Kumar, Prashanth, Cai, Luke L., Sun, Ramon C., Chaudhary, Kunal R., Cheng, Simon K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359947/ https://www.ncbi.nlm.nih.gov/pubmed/35958336 http://dx.doi.org/10.21037/tlcr-22-292 |
Ejemplares similares
-
Prevalence of Estrogen Receptor Alpha (ESR1) Somatic Mutations in Breast Cancer
por: Kinslow, Connor J, et al.
Publicado: (2022) -
Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer
por: Chaudhary, Kunal R., et al.
Publicado: (2022) -
Outcomes for localized treatment of large cell neuroendocrine carcinoma of the lung in the United States
por: May, Michael S., et al.
Publicado: (2021) -
Loss of FBXL14 promotes mesenchymal shift and radioresistance of non-small cell lung cancer by TWIST1 stabilization
por: Cui, Yan-Hong, et al.
Publicado: (2021) -
And‐1 O‐GlcNAcylation regulates homologous recombination repair and radioresistance in colorectal cancer
por: Zhou, Yuan, et al.
Publicado: (2022)